Ketorolac tromethamine compositions for treating or preventing ocular pain
AssigneeAllergan, Inc.
InventorsEldon Quinn Farnes, Mayassa Attar, Rhett M. Schiffman, Chin-Ming Chang, Richard S. Graham, Devin F. Welty
Life of this patent
Estimating the term…
Abstract
The present invention provides an aqueous ophthalmic solution comprising an effective amount of ketorolac which comprises carboxymethyl cellulose in an aqueous solution which provides increased visual acuity in users and wherein said concentration of carboxymethyl cellulose is selected to provide an increased absorption of ketorolac in the eye of a patient which is at least 130% greater than the absorption of a comparative aqueous ketorolac ophthalmic solution having the same concentration of ketorolac.
Claims20
A topical aqueous ophthalmic solution comprising ketorolac tromethamine, mixtures of carboxymethyl cellulose, containing no preservative and having a pH within the range of approximately 6.8-7.4.
Dependencies are inferred from the claim text.